Remove tag health-innovation-fund
article thumbnail

bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval

pharmaphorum

million price tag attached to the therapy when it was first made available in Europe, and is also well above the proposed $2.1 The company said it would give a treatment guarantee with the product, offering to reimburse health insurers up to 80% of the cost if Zynteglo stops working in the two years after it is administered.

FDA 52
article thumbnail

Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

PM360

Simply getting a patient into a physician’s practice doesn’t guarantee that a product will be utilized or paid for by health plans or self-insured companies. This option grows more critical as new therapies become available with price tags as high as $3.5 million for the new hemophilia gene therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dedi Gilad

Cadensee

02:58 What is the driving force behind your passion for Health Technology? 07:14 What is the difference between being an intrapreneur that innovates within an organization, and an entrepreneur? 15:03 Let's talk about Alike Health, what does Alike do? Do you think raising a seed fund from one VC investor is advantageous?

article thumbnail

Prescription drug prices are out of cotrol

World of DTC Marketing

The May 2021 KFF Health Tracking Poll finds about two-thirds of adults say there is “not as much regulation as there should be” when it comes to limiting the price of prescription drugs. Source: Public Opinion on Prescription Drugs and Their Prices , Filling the need for trusted information on national health issues.